NEW YORK, Feb. 7, 2011 (GLOBE NEWSWIRE) -- Ventrus Biosciences, Inc. (Nasdaq:VTUS), a pharmaceutical company focused on developing and commercializing gastrointestinal products, announced today that Dr. Russell Ellison, the company's president and chief executive officer will be presenting at the 2011 BIO CEO & Investor Conference on Monday, February 14 at 9:00 am (ET) at the Waldorf Astoria in New York.
A live audio webcast and replay of the panel will be available on the "Investors" section of the Company's website.